Articles: 17 Results Search help Filter results »
Sort by: Relevance | Date
Strong evidence for clinical and cost effectiveness of alcohol screening.

NICE to develop alcohol screening QOF targets

GPs could be asked to screen certain patients for alcohol misuse, after NICE advisors approved the d...

QOF targets for long-term depression would increase its priority in care plans

Call for QOF to help people with long-term depression

Introducing QOF targets for long-term depression would improve management of the condition and help ...

Prime minister David Cameron: dementia challenge must not be underestimated

GPs told to boost dementia diagnoses

GP surgeries will be sent 'dementia toolkits' and asked to improve detection of dementia as part of ...

Patients on antidepressants benefit from regular reviews of their medication

Quarter of antidepressant users 'on wrong dose'

A quarter of patients on long-term antidepressants may benefit from a change in dose and a simple re...

Anxiety: can lead to increased mortality risk

Mild anxiety raises mortality risk

Even mild anxiety or depression can raise a person's risk of dying prematurely, a major study sugges...

Axial FLAIR images show abnormal high signal intensity in the mammillary bodies (white arrows), periaqueductal area (black arrow) (Author Images)

Evidence base: Alcohol-related brain damage

Guidelines and online resources for the management of alcohol-related brain damage...

Axial FLAIR images show abnormal high signal intensity in the  mammillary bodies (white arrows), periaqueductal area (black arrow) (Author Images)

Clinical Review - Alcohol-related brain damage

How to identify and manage alcohol-related brain damage, including Wernicke-Korsakoff syndrome. By D...

GPs should screen millions for dementia, MPs say

Millions of patients at risk of dementia could be screened for early signs of the disease to improve...

Coloured PET scan of schizophrenia patient's brain during hallucination (orange areas: brain activity) (Photograph: SPL)

Clinical Review - Schizophrenia

The latest advice and guidance on diagnosing and managing schizophrenia. By Dr Jonathan Mitchell and...

Memantine was found not to reduce significant agitation in patients with Alzhemier's disease

Alzheimer's drug memantine does not cut agitation

The Alzheimer's disease drug memantine improves cognitive function, but does not reduce clinically s...

Didn't find what you were looking for? Search again or try our Search help
Would you like to repeat your search on

Refine your search

By Area

By Date

By Therapeutic area